CO-DEVELOPMENT, COLLABORATION AND LICENSE AGREEMENT BY AND BETWEEN ENZON PHARMACEUTICALS, INC. AND JAGOTEC, AG, SKYEPHARMA, INC., AND SKYEPHARMA PLC DATED AS OF JANUARY 2, 2003Co-Development, Collaboration and License Agreement • December 3rd, 2010 • Pacira Pharmaceuticals, Inc. • Pharmaceutical preparations • New York
Contract Type FiledDecember 3rd, 2010 Company Industry JurisdictionThis CO-DEVELOPMENT, COLLABORATION AND LICENSE AGREEMENT, dated as of January 2, 2003 (the “Effective Date”), is entered into by and among Enzon Pharmaceuticals, Inc., a corporation organized and existing under the laws of Delaware, having offices located at 685 Route 202/206 Bridgewater, New Jersey 08807 (“Enzon”), and SkyePharma, Inc., a corporation organized and existing under the laws of the State of California and wholly-owned subsidiary of Parent, having offices located at 1450 Science Center Drive, San Diego, California 92121 (“Skye”), Jagotec, AG, a corporation organized and existing under the laws of Switzerland and wholly-owned subsidiary of Parent, having offices located at Eptingerstrasse 51, CH-4132 Muttenz, Switzerland (“Jagotec,” and together with Skye, “SkyePharma”), and solely with respect to Section 13.3, SkyePharma PLC, a corporation organized and existing under the laws of England and Wales, having offices located at 105 Piccadilly, London W1J 7NJ, England (“Parent”